Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer.
Clinical trial NCT02870699 · COMPLETED
Trial details
- NCT number
- NCT02870699
- Sponsor
- Institut de Cancérologie de Lorraine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.